MilliporeSigma
Search Within
Applied Filters:
Keyword:'h5270'
Showing 1-30 of 31 results for "

h5270

" within Papers
Annesofie Faurschou et al.
Archives of dermatology, 144(5), 620-624 (2008-05-21)
To examine the effect of topical corticosteroid treatment on acute sunburn. Randomized, double-blind clinical trial. University dermatology department. Twenty healthy volunteers with Fitzpatrick skin types I (highly sensitive, always burns easily, tans minimally) through III (sun-sensitive skin, sometimes burns, slowly
Alfonso Pérez-Garrido et al.
Bioorganic & medicinal chemistry, 17(2), 896-904 (2008-12-06)
This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoretical molecular descriptors, calculated solely from the molecular structure of the compounds under investigation
G E Piérard
Revue medicale de Liege, 61(2), 128-130 (2006-03-29)
Since half a century, dermocorticoids represent worthy compounds in dermatological therapy. About thirty years ago, hydrocortisone 17-butyrate was introduced on the Belgian market. This compound combines good efficiency and reduced risk of side effects. Its topical formulations have been enriched
Dina Vind-Kezunovic et al.
Contact dermatitis, 64(6), 325-329 (2011-04-05)
Corticosteroids are used to treat dermatoses, including allergic contact dermatitis, but can also cause contact allergy. The frequency of corticosteroid allergy varies between studies and is influenced by treatment traditions and availability. To estimate the prevalence of tixocortol-21-pivalate, budesonide and
Mari Paz Castanedo-Tardan et al.
Pediatric dermatology, 26(6), 739-743 (2010-03-05)
Upon ingestion, the artificial sweetener, aspartame is metabolized to formaldehyde in the body and has been reportedly associated with systemic contact dermatitis in patients exquisitely sensitive to formaldehyde. We present a case of a 9-year-old Caucasian boy with a history
Joseph F Fowler et al.
Cutis, 75(2), 125-131 (2005-03-19)
This multicenter, randomized, double-blind clinical trial involving 89 subjects (86 with chronic hand dermatitis and 3 with atopic dermatitis) compared the safety, efficacy, and cosmetic acceptability of 4 medium-potency topical corticosteroid products: hydrocortisone butyrate (HB) 0.1% cream (Locoid Lipocream), fluticasone
Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis.
Rebekah Wilson et al.
Journal of the American Academy of Dermatology, 60(1), 166-168 (2008-12-24)
Louise B Jensen et al.
International journal of pharmaceutics, 390(1), 53-60 (2009-10-20)
Solid lipid nanoparticles (SLN) show promise as a drug delivery system for skin administration. The solid state of the lipid particle enables efficient drug encapsulation and controlled drug release. The present study addresses the influence of lipid composition and drug
C De Waure et al.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 148(5), 471-477 (2013-09-06)
This study assesses the efficacy of a new non steroid anti-inflammatory product in comparison to Hydrocortisone Butyrate 0.1% Cream in healing eczematous dermatitis. A bilateral controlled randomized pilot study was conducted in Italian adults affected by eczema with at least
Nummular allergic contact dermatitis after scabies treatment.
R Kaminska et al.
Contact dermatitis, 48(6), 337-337 (2003-10-09)
Allergic contact dermatitis induced by topical hydrocortisone-17-butyrate mimicking papular rosacea.
Angelo Massimiliano D'Erme et al.
Dermatitis : contact, atopic, occupational, drug, 23(2), 95-96 (2012-06-02)
Cushing's syndrome secondary to topical corticosteroids abuse.
Bahri Ermis et al.
Clinical endocrinology, 58(6), 795-796 (2003-06-05)
Robert Matheson et al.
Journal of drugs in dermatology : JDD, 7(3), 266-271 (2008-04-03)
Hydrocortisone butyrate (HCB) is currently marketed as a cream, ointment, and solution. A new lotion formulation of hydrocortisone butyrate 0.1% (Locoid lotion) has been developed and evaluated. The objective of this study was to evaluate the efficacy and safety of
M Kawashima et al.
The British journal of dermatology, 148(6), 1212-1221 (2003-06-28)
Fexofenadine, a nonsedating, H1-receptor selective antihistamine, exhibits consistent efficacy and safety in the treatment of allergic rhinitis and urticaria. The pruritus associated with atopic dermatitis is considered to be induced, in part, by histamine. Therefore, we thought that fexofenadine may
Hidemi Nakagawa
Clinical drug investigation, 26(5), 235-246 (2006-12-14)
Tacrolimus (FK506) ointment is widely used in the treatment of patients with atopic dermatitis. The drug exerts its action by down-regulating antigen-specific T-cell activities and associated proinflammatory cytokine production. A number of clinical studies have evaluated the efficacy and safety
S Reitamo et al.
The British journal of dermatology, 152(6), 1282-1289 (2005-06-14)
Atopic dermatis (AD) is a chronic disease that often requires long-term treatment. Topical corticosteroids are the usual therapy for patients with AD, but prolonged usage can result in skin atrophy and other side-effects. In a randomized, double-blind, comparative study, to
Corticosteroid contact allergy--the importance of late readings and testing with corticosteroids used by the patients.
Marléne Isaksson
Contact dermatitis, 56(1), 56-57 (2006-12-21)
Alexandre Guichard et al.
International journal of pharmaceutics, 479(2), 422-429 (2015-01-04)
Topical-corticosteroids are mainly used for the treatment of inflammatory or hyperproliferative skin diseases. The in vivo assay to rank topical-corticosteroids potency, based on the skin blanching, is not adapted to compare their anti-proliferative efficacy. We have compared the antiproliferative effect
E Xhauflaire-Uhoda et al.
Revue medicale de Liege, 62(3), 129-131 (2007-05-22)
Suffering from dry skin on the hands is a common feature in the general population. This condition is influenced by daily habits and occupational duties. It commonly corresponds to the expression of irritation dermatitis modulated by climatic and other environmental
M Caproni et al.
Clinical and experimental dermatology, 31(6), 813-817 (2006-10-17)
Topical tacrolimus represents an effective and well-tolerated treatment for atopic dermatitis (AD). Its known effects include reduced production of proinflammatory cytokines and reduced chemokine gradient. We performed lesional skin biopsies on adult patients affected by moderate-to-severe AD. Then, patients were
F Sassi et al.
The British journal of dermatology, 159(5), 1186-1191 (2008-08-23)
Vitiligo is a pigmentary disorder which may have disfiguring consequences. Its treatment remains a challenge. We designed a parallel-group randomized controlled trial to compare the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in
Lawrence Eichenfield et al.
Pediatric dermatology, 24(1), 81-84 (2007-02-16)
Corticosteroids are currently the first line of treatment for patients with atopic dermatitis. In the pediatric population however, the potential impact of adrenal suppression is always an important safety concern. Twenty boys and girls, 5-12 years of age, with normal
[Locoid contains citric acid].
Kirsten Søndergaard
Ugeskrift for laeger, 168(11), 1147-1147 (2006-03-21)
Hans Christian Korting et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 3(5), 348-353 (2005-12-24)
Topical corticosteroids are the treatment of choice for numerous inflammatory or hyperproliferative skin diseases. The vasoconstriction assay is suitable to determinate corticosteroid activity. 60 healthy volunteers were studied. Three corticosteroids in both cream and ointment bases, as well as one
Xiaoyan Yang et al.
AAPS PharmSciTech, 15(3), 569-587 (2014-02-08)
The aim of this investigation was to develop hydrocortisone butyrate (HB)-loaded poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NP) with ideal encapsulation efficiency (EE), particle size, and drug loading (DL) under emulsion solvent evaporation technique utilizing various experimental statistical design modules. Experimental designs
A I Lauerma
Contact dermatitis, 24(2), 123-130 (1991-02-01)
3 corticosteroids have so far been tried as markers for corticosteroid contact sensitivity: hydrocortisone, tixocortol pivalate and hydrocortisone-17-butyrate. The present study compared these steroids for screening in addition to a standard patch test series. Of 727 patients, 28 (3.9%) reacted
Sunmin Park et al.
Molecular medicine reports, 12(5), 7657-7664 (2015-09-24)
Atopic dermatitis is a chronic inflammatory skin disease, and salt-processed Phellodendron amurense (CPE) and Sanguisorba officinalis Linne (SOE) are widely used as anti-inflammatory agents in Asia. Therefore, the present study investigated the efficacy of CPE, SOE, and CPE+SOE in the
Allergic contact dermatitis from a topical corticosteroid mimicking acute generalized exanthematous pustulosis.
Sigurd Broesby-Olsen et al.
Acta dermato-venereologica, 85(5), 444-445 (2005-09-15)
Vitiligo.
Luigi Naldi et al.
The New England journal of medicine, 360(17), 1788-1788 (2009-04-24)
P Mercy et al.
Indian journal of dermatology, venereology and leprology, 73(6), 415-416 (2007-11-23)
Acquired Blaschkoid dermatitis characterised by unilateral relapsing inflammatory disease along the lines of Blaschko. A 40-year-old Indian male presented with unilateral erythematous, itchy grouped papules on the left side of the chest, abdomen, back and left arm of 15 days
Page 1 of 2
Page 1 of 2